[News Brief] China Approves Enhertu for Second-Line Gastric Cancer
China’s authorities have approved Enhertu (trastuzumab deruxtecan) as the first HER2-directed antibody-drug conjugate for patients with HER2-positive metastatic gastric cancer.…
China’s authorities have approved Enhertu (trastuzumab deruxtecan) as the first HER2-directed antibody-drug conjugate for patients with HER2-positive metastatic gastric cancer.…
Daiichi Sankyo has announced a leadership transition at its Translational Research Centre Europe, with Veronika Müller succeeding Jürgen Müller. This…
Kowa Co., Ltd has announced the launch in Singapore of GLA-ALPHA® Combination Ophthalmic Solution, a new fixed-dose eye drop licensed…
Rhinocare Korea has announced a Singapore-based joint venture to serve as its regional headquarters for drug-free respiratory therapy devices. This…
The Chinese University of Hong Kong (CUHK) and MicroSigX have teamed up to launch an AI-powered test to aid early…
KLMBio, a South Korean manufacturer of human tissue-based medical devices, is broadening its presence in the global bone graft market.…
The Asia Summit on Global Health (ASGH) 2026 will be held at the Hong Kong Convention and Exhibition Centre from…
Sisram Medical has signed a memorandum with Sinmait Medical Technology to establish a manufacturing and innovation centre focused on energy-based…
pixelRo, a digital healthcare company, will highlight its AI-powered self-diagnostic solutions and air sterilisation technologies at both CES 2026 and…
Indonesia and China have agreed to establish a Joint Laboratory for Digital Medicine and Proactive Health to advance artificial intelligence…